Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Kaushik Abhyankar"'
Autor:
Christina Pamporaki, PD, Annika M A Berends, PhD, Angelos Filippatos, ProfPhD, Tamara Prodanov, PhD, Leah Meuter, MD, Alexander Prejbisz, ProfPhD, Felix Beuschlein, ProfPhD, Martin Fassnacht, ProfPhD, Henri J L M Timmers, ProfPhD, Svenja Nölting, ProfPhD, Kaushik Abhyankar, Dipl-Ing, Georgiana Constantinescu, MD, Carola Kunath, Robbert J de Haas, PhD, Katharina Wang, Staatsexa, Hanna Remde, PhD, Stefan R Bornstein, ProfPhD, Andrzeij Januszewicz, ProfPhD, Mercedes Robledo, ProfPhD, Jacques W M Lenders, ProfPhD, Michiel N Kerstens, PhD, Karel Pacak, ProfDrSc, Graeme Eisenhofer, ProfPhD
Publikováno v:
The Lancet: Digital Health, Vol 5, Iss 9, Pp e551-e559 (2023)
Summary: Background: Pheochromocytomas and paragangliomas have up to a 20% rate of metastatic disease that cannot be reliably predicted. This study prospectively assessed whether the dopamine metabolite, methoxytyramine, might predict metastatic dise
Externí odkaz:
https://doaj.org/article/1f2317257660451eb856fc839fb1ec17
Autor:
Angelos Filippatos, Dionysios Markatos, Georgios Tzortzinis, Kaushik Abhyankar, Sonia Malefaki, Maik Gude, Spiros Pantelakis
Publikováno v:
Aerospace, Vol 11, Iss 1, p 86 (2024)
The current prevailing trend in design across key sectors prioritizes eco-design, emphasizing considerations of environmental aspects in the design process. The present work aims to take a significant leap forward by proposing a design process where
Externí odkaz:
https://doaj.org/article/58f0c267c606414d82e27d8b051812d4
Autor:
Chritina Pamporaki, Annika M.A. Berends, Angelos Filippatos, Tamara Prodanov, Leah Meuter, Alexander Prejbisz, Felix Beuschlein, Martin Fassnacht, Henri J.L.M Timmers, Svenja Nölting, Kaushik Abhyankar, Georgiana Constantinescu, Carola Kunath, Robbert J. de Haas, Katharina Wang, Hanna Remde, Stefan R. Bornstein, Andrzeij Januszewicz, Mercedes Robledo, Jacques W.M. Lenders1, Michiel N. Kerstens, Karel Pacak, Graeme Eisenhofer
Background: Pheochromocytomas and paragangliomas (PPGL) have up to 20% rate of metastatic disease that cannot be reliably predicted. This study prospectively assessed whether the dopamine metabolite, methoxytyramine, might predict metastatic disease,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9862affcd4146bd337691e2a1e9051c2